Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 158Terminated 56Recruiting 22Unknown 21Active not recruiting 17Withdrawn 11Not yet recruiting 5Suspended 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other solid neoplasm 1

Conditions

Prostatic Neoplasms 2Lung Neoplasms 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms 1NSCLC 1Mesothelioma 1Breast Neoplasms 1

Interventions

Nivolumab 2Docetaxel 2tivozanib 1gallium 68 PSMA-11 1atezolizumab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Specimen Handling 1Paclitaxel 1Oxycodone 1Menogaril 1Magnetic Resonance Imaging 1Ketorolac 1Ketamine 1Interleukin-2 1Genome 1Genetic Testing 1Etoposide 1Cisplatin 1Carboplatin 1CYT003-QbG10 1Biopsy 1Acetaminophen 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × Docetaxel × Clear all
NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00127088 2006-09-11

Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Suspended
37 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡